Novotel London West - 13 May 2014 15:50. Michalis Papadakis, CEO of Brainomix Ltd, today announced that he will present at BioTrinity 2014, Europe’s leading Biopartnering and Investment Conference, to be held on 12-14 May at the Novotel London West.
Founded and produced by OBN, BioTrinity is now in its eighth year. BioTrinity has grown rapidly over recent years, and is now located in London to accommodate increased interest. More than 1000 senior executives and decision makers from emerging and established companies across the life sciences sector and investment firms are expected to meet one-on-one, attend panel discussions, company showcases and workshops, or browse the company showcases, seeking out their next deals.
Jon Rees, CEO of OBN, said: “BioTrinity has become the ‘must attend’ life sciences conference for emerging European companies, investors and partners. We are excited to be hosting what we believe will be the greatest business development opportunity of 2014. This announcement from Brainomix confirms that this is an event that deal and decision makers cannot afford to miss.”